+499.5%
MRNA vs CSGP
-64.9%
+564.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CSGP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.4% | +0.2% | +0.1% |
| 7D | +5.5% | -4.1% | +9.5% | +9.8% |
| 30D | +158.7% | +2.3% | +156.4% | +174.5% |
| 3M | +182.1% | -8.2% | +190.3% | +204.3% |
| 6M | +151.8% | -35.1% | +186.9% | +205.1% |
| YTD | +393.6% | -54.0% | +447.6% | +565.8% |
| 1Y | +499.5% | -65.3% | +564.8% | +825.0% |
| All | +499.5% | -64.9% | +564.4% | +825.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CSGP.
Daily Out/Under-Performance
Portfolio return minus CSGP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CSGP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CSGP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling